Cancellation of state registration. Uregit®

April 10, 2018
Active substances:
Trade names:
ICD-10:
VI.G90-G99.G93.6    Edema of the brain
IX.I10-I15.I10    Essential [primary] hypertension
IX.I30-I52.I50.0    Congestive heart failure
IX.I30-I52.I50.1    Left ventricular failure
X.J80-J84.J81    Pulmonary edema
XI.K70-K77.K74    Fibrosis and cirrhosis of the liver
XIV.N00-N08.N04    Nephrotic syndrome
Uregit, ethacrynic acid, diuretic, cerebral edema, edematous syndrome, chronic heart failure, portal hypertension syndrome, nephrotic syndrome

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state register of medicinal products for medical use of the medicinal product (registration certificate P N012429 / 01 from 05.09.2011 issued to JSC "Pharmaceutical Plant EGIS", Hungary):

Uregit® (trade name of the medicinal product)

Ethcarinic acid (international non-proprietary or grouping or chemical name)

tablets, 50 mg (dosage form, dosage)

ZAO "Pharmaceutical Plant EGIS", Hungary 1165 Budabest, Bokenyfoldi ut 118-120, Hungary (name and address of the location of the manufacturer of the medicinal product)

on the basis of the application by the authorized legal entity of the Representative Office of ZAO "Pharmaceutical Plant EGIS" to cancel the state registration of the medicinal product.